BRWA
ELDN icon

B. Riley Wealth Advisors’s Eledon Pharmaceuticals ELDN Stock Holding History

B. Riley Wealth Advisors’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-15,000
Closed -$273K – 821
2019
Q2 		$273K Buy
15,000
+6,127
+69% +$268K 0.03% 606
2019
Q1 		$643K Buy
8,873
+2,194
+33% +$146K 0.08% 271
2018
Q4 		$193K Buy
6,679
+4,179
+167% +$267K 0.03% 582
2018
Q3 		$211K Buy
2,500
+1,939
+346% +$198K 0.03% 629
2018
Q2 		$71K Buy
+561
New +$58K 0.01% 652

Other funds holding ELDN

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

B. Riley Wealth Advisors's ELDN Position: Q3 2019 in Review

B. Riley Wealth Advisors sold out of Eledon Pharmaceuticals (ELDN) in Q3 2019, closing a stake of 15,000 shares — an estimated $273K sold.

B. Riley Wealth Advisors first reported a position in ELDN in Q2 2018 and held it in 5 quarters. The position peaked at $643K in Q1 2019. 15 funds tracked by Wall St. Rank hold ELDN as of Q3 2019.

  • B. Riley Wealth Advisors reported no remaining Eledon Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 15,000 Eledon Pharmaceuticals shares in Q3 2019, an estimated $273K.
  • B. Riley Wealth Advisors first reported a position in Eledon Pharmaceuticals in Q2 2018 and held it in 5 quarters.
  • B. Riley Wealth Advisors's Eledon Pharmaceuticals position peaked at $643K in Q1 2019.
  • 15 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q3 2019.

Based on B. Riley Wealth Advisors's 13F filing for Q3 2019, filed 12 Nov 2019.